Offering you a complete choice of products which include erlocip 150 mg erltinib tablet, tagrisso 80mg osimertinib tablets, alecensa alectinib 150 mg capsules, 1200mg tecentriq atezolizumab injection, crizotinib 250mg tablet and imfinzi 500mg durvalumab injection.
₹ 8640 / Bottle Get Latest Price
| Strength | 150 mg |
| Pack Size | 1*30 Tablet |
| Pack Type | Box |
| Brand Name | Erlocip 150 mg |
| Manufacturer | Cipla |
| Usages | Personal |
| Country of Origin | Made in India |
| Composition | Erltinib |
| Treatment | Non-small cell lung cancer |
| Form | Tablet |
| Shelf Life | 24 months |
Minimum order quantity: 10 Bottle
Introduction
Erlocip 150 Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer. 150 Tablet should be consumed on an empty stomach, one hour prior to, or two hours following, a meal. As long as your doctor recommends it, you should keep taking it. Depending on your needs and how you respond to treatment, the length of treatment varies.
You should follow your doctor's instructions to the letter. It can have potentially dangerous negative effects if taken improperly or in excess. The benefits might not become apparent to you for a few weeks or months, but you shouldn't stop taking it until your doctor instructs you to.The most common side effects of this medicine include nausea, vomiting, fatigue, rash, and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you.
It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using.
This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. It is advised to quit smoking while taking this medicine as it can affect the working of the medicine. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.
Uses :
Non-small cell lung cancerPancreatic cancer
Benefits :
In Non-small cell lung cancer:
Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Erlocip 150 Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
In Pancreatic cancer :
Pancreas are very essential for digestion of whatever you eat and also for metabolism of blood sugar levels as they produce the body’s natural insulin. This medicine will help to control pancreatic cancer, and will relieve the symptoms such as, lack of appetite or unexplained weight loss. Erlocip 150 Tablet helps to stop the action of those chemicals that aid in pancreatic cancer growth and spread. It will help you live a longer and healthier life.
Side Effects :
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Common side effects of Erlocip :
Abdominal pain
Bone pain
Breathlessness
Constipation
Cough
Diarrhea
Fatigue
Fever
Infection
Muscle pain
Nausea
Rash
Stomatitis (Inflammation of the mouth)
Vomiting
Weight loss
₹ 151009 / Box Get Latest Price
| Strength | 80mg |
| Tablets per Pack | 30 Tablets |
| Brand | Tagrisso |
| Form | Tablet |
| Packaging Type | Box |
| Treatment | Non-small cell lung cancer |
| Manufacturer | AstraZeneca |
| Composition | Osimertinib |
| Shelf Life | 24 Months |
Minimum order quantity: 1 Box
Tagrisso 80mg Osimertinib Tablets
Product Introduction:
A protein kinase inhibitor called Tagrisso 80mg Tablet is used to treat non-small cell lung cancer. Adult patients with certain estimated glomerular filtration rate (EGFR) mutations are treated with it.
The Tagrisso 80mg Tablet can be taken with or without food, however for optimal results, try taking it at the same time each day. The recommended dosage and frequency of administration will be determined by your physician. This will vary depending on the condition for which you are receiving treatment. You should take it exactly as prescribed by your physician. Very dangerous negative effects can result from taking it incorrectly or in excess. You might not notice or feel the advantages for a few weeks or months, but don't stop taking it until your doctor instructs you to.
This medication frequently causes diarrhea, so stay hydrated. But if it doesn't stop, you have to let your doctor know. If you have severe skin peeling, fever, coughing, or breathing difficulties, you must notify your doctor. This medication may cause your blood's white blood cell count to drop, making you more vulnerable to infections. To check your blood cells, you must undergo routine blood testing.
Uses of Tagrisso Tablet
• Non-small cell lung cancer
BENEFITS OF TAGRISSO TABLET
In Non-small cell lung cancer
One of the most common types of lung cancer that affects both smokers and non-smokers is non-small cell lung cancer. Tagrisso 80mg Tablets can be taken either by themselves or in conjunction with other medications to help treat non-small cell lung cancer. You should talk to your doctor about the advantages and disadvantages of this powerful and highly poisonous medication. While receiving this medication, you should abstain from alcohol and stay hydrated by drinking lots of water.
₹ 124520 / Box Get Latest Price
| Strength | 150 mg |
| Packaging Size | 240 Capsules |
| Pack Size | 240 Capsules |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
| Composition | Alectinib 150 mg |
| Brand | Alecensa |
| Manufacturer | ROCHE PRODUCTS INDIA PVT LTD |
| Shelf Life | 24 Months |
Minimum order quantity: 10 Box
₹ 55059 / Vial Get Latest Price
| Strength | 1200 mg/20 ml |
| Packaging Type | Vial |
| Pack Size | 20 ml |
| Brand | Tecentriq |
| Treatment | Small cell Lung Cancer |
| Manufacturer | Roche Products India Pvt Ltd |
| Composition | Atrzolizumab |
| Shelf Life | 24 Months |
Minimum order quantity: 3 Vial
Tec-ent-riq Atezolizumab 1200 mg/20 ml Injection
Product Introduction
1200 mg of Tecentriq Monoclonal antibodies are a class of medications that includes injections. Hepatocellular carcinoma, melanoma, small cell lung cancer, and non-small cell lung cancer are all treated with it.
1200 mg of Tecentriq Injections are administered under a physician's supervision into veins. The recommended dosage and frequency of administration will be determined by your physician. This will vary depending on the condition for which you are receiving treatment. You should take it exactly as prescribed by your physician. Very dangerous negative effects can result from taking it incorrectly or in excess. You might not notice or feel the advantages for a few weeks or months, but don't stop taking it until your doctor instructs you to.
Inform your doctor before taking it if you have liver, kidney, or heart illness, or if you take any medications for infections. Tell your healthcare provider about all the medications you take because many other medications can either impact or be affected by this medication. It is not advised to use this medication when nursing or pregnant. It is crucial for both men and women to use adequate contraception during therapy in order to prevent conception.
For this medication, Tata 1mg offers a Patient Support Program/Patient Assistance Program in India.
Uses of Tecentriq
Treatment of Small cell lung cancer
Non-small cell lung cancer
Melanoma
Treatment of Hepatocellular carcinoma
Benefits of Tecentriq
In Treatment of Small cell lung cancer
Malignant (cancerous) cells develop in the lung tissues in small cell lung cancer (SCLC). When atezolizumab is added to chemotherapy as a first-line treatment for extensive-stage small-cell lung cancer, overall survival and progression-free survival are considerably longer than when chemotherapy is used alone.
Side effects of Tecentriq Solution for Infusion
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects of Tecentriq
Fatigue
Weakness
Decreased appetite
Nausea
Cough
Breathlessness
Constipation
How to use Tecentriq
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How Tecentriq
Tecentriq 1200mg Injection is a type of monoclonal antibody. It works by blocking the activity of a protein located on the T cells- a type of white blood cells that regulate the functioning of the immune system. In the presence of Tecentriq 1200mg Injection, the killing power of T-cells is restored and the immune response is stimulated to locate and destroy cancer cells.
Safety advice
Alcohol
It is not known whether it is safe to consume alcohol with Tecentriq 1200mg Injection.
Pregnancy
Tecentriq 1200mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Breast feeding
Tecentriq 1200mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
It is not known whether Tecentriq 1200mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
There is limited information available on the use of Tecentriq 1200mg Injection in patients with kidney disease.
₹ 95500 / Bottle Get Latest Price
| Composition | Crizotinib |
| Strength | 250 mg |
| Packaging Size | 60 Capsules |
| Form | Capsule |
| Manufacturer | Pfizer |
| Packaging Type | Bottle |
| Treatment | Lung Cancer |
| Usage / Application | Personal Use |
| Country of Origin | India |
Minimum order quantity: 10 Bottle
₹ 98709 / Vial Get Latest Price
| Strength | 50 mg/10 ml |
| Packaging Type | Vial |
| Brand | Imfinzi |
| Treatment | Lung cancer |
| Composition | Durvalumab |
| Manufacturer | ASTRAZENECA PHARMA INDIA LTD |
| Shelf Life | 24 Months |
Minimum order quantity: 1 Vial
Imfinzi Durvalumab 50 mg/ml Inj - 10 ml
Product Introduction
Imfinzi 500mg injection is an anticancer drug belonging to the class of Anti-PD-1 monoclonal antibodies, containing the active ingredient Durvalumab. It is used to treat non-small cell lung cancer, small cell lung cancer, and biliary tract cancers. Tell your doctor if you have had an organ transplant, liver problems, lung or breathing problems, or autoimmune disease before taking this injection.
This medicine is not recommended for adolescents and children under the age of 18. During the Imfinzi 500mg injection treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. This drug is often used in combination with carboplatin or cisplatin for the treatment of small-cell lung cancer and also used in combination with gemcitabine for the treatment of biliary tract cancer. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with kidney disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment.
Uses of Imfinzi 500mg Injection
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Biliary Tract Cancer
Therapeutic Effects of Imfinzi 500mg Injection
It works by blocking a protein called programmed death-ligand 1 (PD-L1), which is found on the surface of certain cancer cells. When PD-L1 binds to its receptor on T cells, it can inhibit the immune system's ability to recognize and attack cancer cells. By blocking the interaction between PD-L1 and its receptor, this drug allows T cells to recognize and attack cancer cells more effectively. It helps the immune system to fight cancer and potentially slow or stop its growth.
How to consume Imfinzi 500mg Injection
Imfinzi 500mg injection is a prescription drug available in injection form. This injection will be given intravenously into a vein in your arm or hand by a healthcare professional in a hospital setting. Do not self-administer this medicine. The dose of the injection will be decided by your doctor based on your disease condition and other factors. During the infusion, you will be monitored for any side effects or reactions to the medication. The infusion usually takes a few hours to complete, and you may need to receive multiple infusions over the course of several weeks.
Safety Advices for Imfinzi 500mg Injection
Pregnancy
Imfinzi 500mg injection is not recommended for pregnant women as it may cause fetal harm.
Breast Feeding
It is not known if Imfinzi 500mg injection passes into your breast milk or if it will affect your baby.
Liver
Inform your doctor if you have any liver problems before taking Imfinzi 500mg injection. Regular monitoring of liver function tests is recommended.
Alcohol
It is unknown whether consuming alcohol interacts with Imfinzi 500mg injection.
Driving
It is unsafe to drive vehicles or operate heavy machinery after taking Imfinzi 500mg injection; it may cause dizziness and impair your concentration.
Common
Cough
Upper respiratory tract infections
Feeling tired
Shortness of breath
Inflammation in the lungs
Rash
₹ 5059 / Box Get Latest Price
| Strength | 250 mg |
| Brand | Crikzo |
| Packaging Size | 30 Capsules |
| Form | Capsule |
| Dose Type | Oral |
| Indication | ALK+ NSCLC, ROS1+ NSCLC |
| Pack Type | Bottle |
| Shelf Life | 24 Months |
| Composition | Crizotinib |
Minimum order quantity: 10 Box
₹ 87995 / Box Get Latest Price
| Strength | 250 mg |
| Brand | Crizalk |
| Dose/Strength | 250 mg |
| Packaging Size | 120 Capsules |
| Usage/Application | Personal |
| Form | Tablet |
| Manufactured By | PFIZER LTD |
| Compostion | Crizotinib 250 Mg |
| Prescription/Non prescription | Prescription |
| Treatment | Non-small cell lung cancer (NSCLC) |
| Packaging Type | Strip |
Minimum order quantity: 10 Box
PRODUCT DETAILS
CRIZALK 250MG CAPSULE belongs to the group of medicines called anti-cancer medicines. It is used to treat lung cancer called non-small cell lung cancer (NSCLC) in adults. Non-small cell lung cancer is a condition in which malignant (cancer) cells develop in the lung tissues. Non-small cell lung cancer is classified into numerous categories. The most important risk factor for non-small cell lung cancer is smoking.
CRIZALK 250MG CAPSULE contains the active substance Crizotinib, a medicine used to treat adults with lung cancer called non-small cell lung cancer (NSCLC). It works by inhibiting a type of enzyme called tyrosine kinase and slowing down or stopping cancer cell growth. CRIZALK 250MG CAPSULE is only given to patients whose disease is due to an alteration in the gene for ALK tyrosine kinase.
Always use this medicine exactly as your doctor has told you. You must keep to your doctor's instructions to get the maximum benefit. Sometimes, you may experience specific common side effects, such as visual disturbances or stomach upset, including vomiting, diarrhoea, nausea, tiredness, and dizziness. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Do not take CRIZALK 250MG CAPSULE if you are allergic to CRIZALK 250MG CAPSULE or any of its ingredients. CRIZALK 250MG CAPSULE may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with CRIZALK 250MG CAPSULE as it could lead to increased dizziness.
Uses of CRIZALK 250MG CAPSULE
Non-small cell lung cancer (NSCLC)
Medicinal Benefits
CRIZALK 250MG CAPSULE contains the active substance Crizotinib, a medicine used to treat adults with non-small cell lung cancer (NSCLC). CRIZALK 250MG CAPSULE is only given to patients whose disease is due to an alteration in the gene for ALK tyrosine kinase. It works by inhibiting a type of enzyme called tyrosine kinase and slowing down or stopping cancer cell growth.
Directions for Use
Swallow it as a whole with water; do not crush, break or chew it.
Storage
Store in a cool and dry place away from sunlight
Side Effects of CRIZALK 250MG CAPSULE
Visual disturbance
Stomach upset
Vomiting
Diarrhoea
Nausea
Constipation
Decreased appetite
Tiredness
Dizziness
Metallic taste
Abdomen pain
Habit Forming
No
Diet & Lifestyle Advise
Watch out for triggers that worsen the cough, such as smoke, foods, air-conditioning, high altitude, etc.
Exercise moderately. Eat healthily.
Follow a pulmonary rehabilitation program. It includes exercise, disease education, and group therapy.
Quit smoking and alcohol.
Get ample rest.
Include green leafy vegetables, sweet potatoes, broccoli, tomatoes, carrots, mangoes, citrus fruits, berries, and cocoa.
Lean proteins such as fish, meat, and poultry are the best.
Hydration is important. Drink plenty of water, herbal tea, and vegetable and fruit juices.
Avoid processed and refined foods.
Special Advise
If you have a fever or an infection, call your doctor. Your doctor may perform blood tests, and if the findings are abnormal, your doctor may opt to cut the dose of CRIZALK 250MG CAPSULE.
Inform your doctor as soon as possible if you notice any vision loss or changes in your vision, such as difficulties seeing out of one or both eyes.
During your therapy with CRIZALK 250MG CAPSULE, your doctor may recommend electrocardiograms to ensure that your heart is not causing any difficulties.
₹ 194 / Vial Get Latest Price
| Strength | 100 mg |
| Form | Injection |
| Usage/Application | Personal |
| Compostion | Pemetrexed (100mg) |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
| Brand | Pemnat 100 |
| Manufacturer | Natco Pharma Ltd |
| Treatment | Non-small cell lung cancer |
Minimum order quantity: 10 Vial
PRODUCT INTRODUCTION
Pemnat 100mg Injection is used in the treatment of non-small cell lung cancer and malignant pleural mesothelioma.
Pemnat 100mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Before taking it, tell your doctor if have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using.This medicine is not recommended during pregnancy or while breastfeeding. Use of effective contraception by both males and females during treatment is important to avoid pregnancy.
USES OF PEMNAT INJECTION
Non-small cell lung cancer
Malignant pleural mesothelioma
BENEFITS OF PEMNAT INJECTION
In Non-small cell lung cancer
Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Pemnat 100mg Injection helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
SIDE EFFECTS OF PEMNAT INJECTION
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Pemnat
Nausea
Vomiting
Sore throat
Loss of appetite
Stomatitis (Inflammation of the mouth)
Hair loss
Low blood platelets
Rash
Fatigue
Anemia (low number of red blood cells)
Diarrhea
Decreased white blood cell count (neutrophils)
Neuropathy
SAFETY ADVICE
Alcohol
Consuming alcohol with Pemnat 100mg Injection does not cause any harmful side effects.
Pregnancy
Pemnat 100mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks.
Breast feeding
Pemnat 100mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
Pemnat 100mg Injection may cause side effects which could affect your ability to drive.
Pemnat 100mg Injection may make you feel tired and this may affect your ability to drive.
Kidney
Pemnat 100mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Pemnat 100mg Injection may be needed.
Use of Pemnat 100mg Injection is not recommended in patients with moderate to severe kidney disease.
Liver
Pemnat 100mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Pemnat 100mg Injection may not be needed in these patients.
₹ 2287 / Vial Get Latest Price
| Strength | 500 mg |
| Pack Type | Vial |
| Brand Name | Es Peme 500 |
| Manufacturer | Esperer Bioresearch Pvt Ltd |
| Usages | Non-small cell lung cancer & Malignant pleural mesothelioma |
| Country of Origin | Made in India |
| Composition | Pemetrexed 500 mg |
| Form | Injection |
Minimum order quantity: 10 Vial
Tushar Ghanshyambhai Kalathiya (CEO)
Leaf Pharma
Ground Floor Plot No-19 Opp. Govindaji Hall, Dabholi Road, OPP. GOVINDAJI HALL, Surat - 395004, Gujarat, India